ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Isomorphic Labs, a drug discovery company spun out of Google DeepMind, is in talks to raise about $5bn. This potential round would put the company valuation at about $50bn, according to people familiar with the matter. The financing has not closed and details could change.
Tap to vote and see what everyone thinks.
Summary by ByteBrief